A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems-Reference-Cited by-同舟云学术

A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems

Published:2014-06-06 Issue:6 Volume:9 Page:e99115
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lee Yun-Hsuan,Hsu Chia-Yang,Chu Chen-Wei,Liu Po-Hong,Hsia Cheng-Yuan,Huang Yi-Hsiang,Su Chien-Wei,Chiou Yi-You,Lin Han-Chieh,Huo Teh-Ia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Primary liver cancer: worldwide incidence and trends;FX Bosch;Gastroenterology,2004

2. Child CG, Turcotte JG (1964) Surgery and portal hypertension. In: The liver and portal hypertension. Edited by CG Child. Philadelphia: Saunders 50–64.

3. Transection of the oesophagus for bleeding oesophageal varices;RN Pugh;Br J Surg,1973

4. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators;Hepatology

5. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma;JM Llovet;Liver Transpl,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients;Arab Journal of Gastroenterology;2021-09

2. Liver resection is always a good choice for hepatocellular carcinoma (HCC) patients regardless of Barcelona Clinic Liver Cancer (BCLC) stage: the therapeutic hierarchy;Annals of Translational Medicine;2020-10

3. Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then;Annals of Translational Medicine;2020-09

4. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study;PLOS ONE;2019-05-02

5. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort;BMC Cancer;2018-07-31